DGX Quest Diagnostics Inc

Price (delayed)

$138.95

Market cap

$18.15B

P/E Ratio

10.38

Dividend/share

$2.3

EPS

$13.39

Enterprise value

$21.58B

Sector: Healthcare
Industry: Diagnostics & Research

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals ...

Highlights

DGX's EPS has surged by 128% year-on-year and by 26% since the previous quarter
The net income has soared by 127% YoY and by 26% from the previous quarter

Key stats

What are the main financial stats of DGX
Market
Shares outstanding
130.64M
Market cap
$18.15B
Enterprise value
$21.58B
Valuations
Price to earnings (P/E)
10.38
Price to book (P/B)
2.75
Price to sales (P/S)
1.79
EV/EBIT
8.47
EV/EBITDA
7.38
EV/Sales
2.09
Earnings
Revenue
$10.34B
EBIT
$2.55B
EBITDA
$2.93B
Free cash flow
$2.07B
Per share
EPS
$13.39
Free cash flow per share
$15.57
Book value per share
$50.54
Revenue per share
$77.71
TBVPS
$44.51
Balance sheet
Total assets
$13.93B
Total liabilities
$7.14B
Debt
$4.66B
Equity
$6.75B
Working capital
$1.29B
Liquidity
Debt to equity
0.69
Current ratio
1.76
Quick ratio
1.53
Net debt/EBITDA
1.17
Margins
EBITDA margin
28.3%
Gross margin
40.4%
Net margin
17.4%
Operating margin
23.8%
Efficiency
Return on assets
13.1%
Return on equity
28%
Return on invested capital
34%
Return on capital employed
20.8%
Return on sales
24.7%
Dividend
Dividend yield
1.66%
DPS
$2.3
Payout ratio
17.2%

DGX stock price

How has the Quest Diagnostics stock price performed over time
Intraday
0.4%
1 week
5.36%
1 month
8.78%
1 year
29.42%
YTD
16.6%
QTD
8.27%

Financial performance

How have Quest Diagnostics's revenue and profit performed over time
Revenue
$10.34B
Gross profit
$4.18B
Operating income
$2.46B
Net income
$1.8B
Gross margin
40.4%
Net margin
17.4%
The net income has soared by 127% YoY and by 26% from the previous quarter
DGX's operating income has surged by 112% year-on-year and by 25% since the previous quarter
Quest Diagnostics's net margin has surged by 67% YoY and by 14% QoQ
The gross profit has soared by 61% YoY and by 15% from the previous quarter

Growth

What is Quest Diagnostics's growth rate over time

Valuation

What is Quest Diagnostics stock price valuation
P/E
10.38
P/B
2.75
P/S
1.79
EV/EBIT
8.47
EV/EBITDA
7.38
EV/Sales
2.09
DGX's EPS has surged by 128% year-on-year and by 26% since the previous quarter
DGX's price to earnings (P/E) is 39% lower than its 5-year quarterly average of 17.0 and 25% lower than its last 4 quarters average of 13.8
Quest Diagnostics's equity has increased by 19% YoY
The stock's price to book (P/B) is 10% more than its last 4 quarters average of 2.5 and 6% more than its 5-year quarterly average of 2.6
The revenue has grown by 35% YoY and by 10% from the previous quarter

Efficiency

How efficient is Quest Diagnostics business performance
DGX's return on assets has surged by 102% year-on-year and by 21% since the previous quarter
DGX's ROE has soared by 97% year-on-year and by 21% since the previous quarter
Quest Diagnostics's return on invested capital has surged by 95% YoY and by 23% QoQ
DGX's return on sales has surged by 59% year-on-year and by 13% since the previous quarter

Dividends

What is DGX's dividend history
DPS
$2.3
Dividend yield
1.66%
Payout ratio
17.2%
Recent dividends

Financial health

How did Quest Diagnostics financials performed over time
The total assets is 95% greater than the total liabilities
Quest Diagnostics's quick ratio has increased by 32% YoY
The current ratio has increased by 28% YoY and by 2.3% QoQ
Quest Diagnostics's debt is 31% lower than its equity
Quest Diagnostics's equity has increased by 19% YoY
The company's debt to equity fell by 15% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.